Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1998-06-26
2000-11-07
Eyler, Yvonne
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241531, 4241551, 4241561, 4241781, 53038885, 5303917, 5303913, 4353441, 435810, 435975, A61K 39395, C07K 1628, C07K 1630, C12N 516, G01N 3353
Patent
active
061432962
ABSTRACT:
A monoclonal antibody specific to the cell surface glycoprotein CD164 is designated 67D2 and produced by hybridoma cells deposited under No. DSM ACC2303 at the German Collection of Microorganisms and Cell Cultures Ltd., DSMZ.
REFERENCES:
Pancino, G. et al. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D. Cancer Research, 50: 7333-7342, 1990.
Pancino, G. et al. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast. Cancer Research, 47: 4444-4452, 1987.
Buhring Hans-Jorg
Watt Suzanne M.
Eberhard-Karls-Universitat Tubinger
Eyler Yvonne
Hamrick Claude A. S.
Holleran Anne L.
LandOfFree
Antibody 67D2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody 67D2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody 67D2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1638089